[Form 4] IBEX Ltd Insider Trading Activity

Rhea-AI Filing Summary

IBEX Ltd reporting person Julie K. Casteel sold 295 common shares at $29.13 per share on 08/26/2025 to cover tax withholding on vested restricted stock units. After the sale the reporting person beneficially owned 30,895 shares, held directly. The Form 4 indicates the sales were required to satisfy tax obligations and were not discretionary trades, signaling they were routine administrative transactions related to equity compensation rather than a change in investment view.

Insights

Financial Analyst

TL;DR: A small, routine tax-withholding sale; unlikely to affect IBEX's valuation or signal material insider sentiment.

This transaction represents a modest disposal of 295 shares at $29.13 to cover taxes from restricted stock unit vesting. With 30,895 shares remaining beneficially owned, the sale size is negligible relative to typical public-company free float and does not indicate a voluntary monetization strategy. From a financial perspective, this is an administrative equity-compensation event and should not materially affect earnings, cash flow, or shareholder value.

Corporate Governance Expert

TL;DR: Governance norms followed; disclosure is timely and the explanation clarifies the nature of the sale.

The Form 4 discloses the relationship (Officer, Chief Sales/Marketing Officer) and explicitly states the sale was to satisfy tax withholding for vested RSUs. That disclosure aligns with best practices for insider transparency. There is no indication of coordinated disposal or other governance concerns based on the information provided.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Casteel Julie K

(Last) (First) (Middle)

C/O IBEX LIMITED

1717 PENNSYLVANIA AVENUE NW, SUITE 825

(Street)

WASHINGTON DC 20006

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
IBEX Ltd [ IBEX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Sales/Marketing Officer

3. Date of Earliest Transaction (Month/Day/Year)
08/26/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares	08/26/2025		S(1)		295	D	$29.13	30,895	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The sales reported on this Form 4 represent shares of Common Stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units and do not represent discretionary trades by the Reporting Person.

Remarks:

	Lisa Lenstrohm, Attorney-in-Fact	09/15/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Julie K. Casteel disclose in the IBEX (IBEX) Form 4?

The filing reports a sale of 295 common shares at $29.13 per share on 08/26/2025 to cover tax withholding from vested restricted stock units.

How many IBEX shares does the reporting person own after the transaction?

The reporting person beneficially owned 30,895 shares following the reported sale.

Was the sale described in the Form 4 a discretionary trade?

No. The Form 4 states the sales were required to satisfy tax withholding obligations related to RSU vesting and were not discretionary trades.

What is the reporting persons role at IBEX?

The reporting person is reported as an Officer, specifically the Chief Sales/Marketing Officer.

Does this Form 4 indicate a material change in insider ownership?

No. The disposition of 295 shares is small relative to the remaining 30,895 shares beneficially owned and is presented as an administrative tax-withholding sale.